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In his letter, Kalish [1] discusses the potential differences between a per- 
mutation test that is based on the randomization distribution for the random- 
ization actually employed (the correct permutation test) and a test based on 
the randomization distribution for a complete binomial randomization, which 
Kalish terms the standard permutation test. Kalish presents the view that in 
practice correct permutation tests are not necessary for the analysis of clinical 
trials in order to perform tests of the proper size (type I error probability). 
His assertion is that standard permutation tests are adequate even when a 
restricted randomization procedure has actually been employed to assign 
treatments to patients. To support this view Kalish and Begg [2] had previ- 
ously conducted a simulation study based upon data from a collection of 
clinical trials conducted by the Eastern Cooperative Oncology Group (ECOG). 
It is perfectly true that in some cases the standard permutation test yields 
the same result as the restricted randomization permutation test. To put it 
another way, a permutation test based on the correct permutational distri- 
bution is sufficient to yield a test of proper size but is not necessary. Unfor- 
tunately, it has not yet been possible to describe universal conditions under 
which the standard versus the correct permutation tests will yield equivalent 
results and the conditions under which they will differ. In Matts and Lachin 
[3], we showed for the permuted-block design that the difference between 
these test results is directly related to the intrablock correlation coefficient. 
However, the relationship between these tests for the urn randomization has 
not been so simply described. In general, therefore, we feel that the only way 
to know whether or not the correct permutation test makes a difference is to 
actually compute it, or equivalently for a permuted-block randomization, to 
compute the intrablock correlation coefficient. 
One condition under which it is known that the standard versus the correct 
permutation tests will yield different results is in the presence of a linear time 
trend in the patient responses. This is obviously only one of an infinite class 
of systematic trends that might occur. Based on the results of a collection of 
ECOG studies, Kalish and Begg [2] concluded that standard permutation tests, 
and thus ordinary population model tests, are acceptable in practice. This 
may be true of ECOG cancer trials, or of other cancer trials in general, but 
certainly is not true of all clinical trials. In fact, in most long-term clinical trials 
in which patients are recruited over extended periods, perhaps as long as 3 
or more years, it is highly likely that major differences will exist between 
patients recruited early as opposed to late in the study. Therefore, in planning 
the analysis for any one clinical trial, we do not find it reassuring to know 
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that in a relatively small number of trials conducted by the ECOG, the use 
of a standard permutation test did not make a difference. The only way to 
find out whether it will make a difference for any one clinical trial is to actually 
do the analysis using the correct permutation test for that trial. 
Kalish [1] also criticizes the time trend example presented by Wei and 
Lachin [4] because the trend exhibited was quite strong. We agree that this 
was the case. However, we make no claim that such a linear trend is typical. 
Rather, the point was to demonstrate one condition under which the standard 
permutation test yields an incorrect result. Again, the issue is that the standard 
permutation test can yield a result that is different from the correct permutation 
test, and the only way to be sure of the results in any one particular trial is 
to perform the correct analysis. 
Kalish [1] also suggests that a simple analysis that stratifies by time blocks 
of entry may be just as effective in providing a test of proper size as does the 
correct permutation test. This is true if one knows in advance the nature of 
the trend in responses that could then be accounted for by such stratification. 
Unfortunately, this can never be known in practice. Also, the efficiency of 
the time-stratification for any one particular study cannot be known unless 
one compares the simple stratified analysis with the correct permutational 
analysis. 
In conclusion, therefore, we agree that in some cases a correct permuta- 
tional analysis may not be necessary or may be supplanted by a simpler time- 
stratified analysis. Unfortunately, however, one never knows whether these 
assertions will apply for any one particular trial unless the correct permuta- 
tional analysis is also conducted. 
As a final point, Kalish [1] asserts that the use of the correct permutation 
test may in fact reduce power in some circumstances. He uses the example 
of a permuted-block design with B blocks where the intrablock correlation is 
close to zero. In this case the standard permutation test will yield a test of 
the proper size, but with a larger degrees of freedom for error in an ordinary 
ANOVA. The corresponding correct analysis would employ a blocked 
ANOVA with B - 1 degrees of freedom removed from df error. However, 
the impact on power may be negligible. For example, for a trial with 10(3 
patients and 50 blocks of size 2, a blocked analysis requires a t value of 2.01 
at the 5% significance level but an unblocked analysis requires only a slightly 
smaller value of 1.98. As the number of blocks decreases, the larger value 
quickly converges to the smaller value. 
Further, it has been our experience that the ANOVA is rarely used in the 
analysis of the results of clinical trials. Rather, the principal methods employed 
are the X 2 tests for proportions or for life tables, in which case the critical 
value of the test is the same for a blocked and an unblocked analysis. In this 
context, the question then becomes one of comparing the variances for the 
correct versus the standard permutational test. In some cases the standard 
permutational variance will be larger than the correct permutational variance, 
thus yielding a smaller test value and sacrificing power. However, in some 
rare cases, it may actually be the case that the correct permutational variance 
is larger than the standard variance, such as where a negative intrablock 
correlation occurs in a permuted-block design. Although, as described by 
Marts and Lachin [3], this may be extremely unlikely, it is our view that if 
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this event were to arise, the correct p value is provided by the correct per- 
mutation test rather than the standard test, even though the latter may be 
"more significant." 
We feel that many of these points require further study and are of great 
practical interest because correct permutation tests are not as readily available 
or as easy to perform as a t test or a simple X 2 test. Therefore, we encourage 
further research to address the issues raised by Professor Kalish. In our view, 
however, especially in the context of multimillion dollar clinical trials, it makes 
little sense to simply perform a standard permutation or population model 
test because of the assertion that such tests might yield a test of the proper 
size. Unless this assertion could be applied to a particular trial with a prob- 
ability approaching 1, we feel that the correct permutation test should serve 
as the gold standard. 
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